Delivery Order SPE2DB22D2206-SPE2DB25FKD19
Award Date 9/26/25
Potential Completion Date 9/29/25
Potential Value $8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with a ceiling value of $1,354.88 and an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp was awarded a delivery order on April 24, 2025, valued at $6,707.89 for the supply of Novolog 100 Unit/mL Flexpen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is set to be completed by April 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was issued by the Medical Supply Chain division of the Defense Logistics Agency under the federal government's medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,853.05 on August 7, 2025, for the supply of Novolog 100 Unit/mL Flexpen 3mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. As a child order under a...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,405.80 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively as a child contract under AmerisourceBergen's larger DLA prime vendor contract vehicle. The place of performance is listed as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $5,262.89 on August 22, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a $1,284.48 delivery order by the Defense Logistics Agency for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 1, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,206.33 and a firm fixed-price structure. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract is set to be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for NovoLog 100 Unit/mL FlexPen 3mL insulin pens with a ceiling value of $5,938.50. This firm fixed price delivery order, awarded on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a non-competitive award under an existing contract vehicle. The award supports the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $7,027.17 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. The contract, issued on April 30, 2025, with an ultimate completion date of May 1, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Medical Supply Chain (a component of the Department of Defense) on September 11, 2025, for NovoLog Mix 70-30 FlexPen 3mL insulin pens. This firm fixed-price delivery order, valued at $4,500.30, represents a non-competitive set-aside contract with an ultimate completion date of September 12, 2025. The place of performance is listed as Conshohocken,...